{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:39:23Z","timestamp":1792931963512,"version":"4.5.0"},"reference-count":256,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12015-025-11016-1","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:18:45Z","timestamp":1761977925000},"page":"296-323","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Regulating Ferroptosis in Leukemic Stem Cells: From Stemness Preservation to Targeted Differentiation Strategies"],"prefix":"10.1007","volume":"22","author":[{"given":"Zexin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"key":"11016_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.6004\/jnccn.2021.0002","volume":"19","author":"DA Pollyea","year":"2021","unstructured":"Pollyea, D. A., Bixby, D., Perl, A., et al. (2021). NCCN guidelines insights: Acute myeloid leukemia, version 2.2021. Journal of the National Comprehensive Cancer Network, 19, 16\u201327. https:\/\/doi.org\/10.6004\/jnccn.2021.0002","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"11016_CR2","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/bjc.2017.281","volume":"117","author":"PA Cassier","year":"2017","unstructured":"Cassier, P. A., Castets, M., Belhabri, A., & Vey, N. (2017). Targeting apoptosis in acute myeloid leukaemia. British Journal of Cancer, 117, 1089\u20131098. https:\/\/doi.org\/10.1038\/bjc.2017.281","journal-title":"British Journal of Cancer"},{"key":"11016_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000533990","volume":"147","author":"EC Chen","year":"2024","unstructured":"Chen, E. C., & Garcia, J. S. (2024). Immunotherapy for acute myeloid leukemia: Current trends, challenges, and strategies. Acta Haematologica, 147, 198\u2013218. https:\/\/doi.org\/10.1159\/000533990","journal-title":"Acta Haematologica"},{"key":"11016_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01521-5","volume":"8","author":"L Tang","year":"2023","unstructured":"Tang, L., Huang, Z., Mei, H., & Hu, Y. (2023). Immunotherapy in hematologic malignancies: Achievements, challenges and future prospects. Signal Transduction and Targeted Therapy, 8, Article 306. https:\/\/doi.org\/10.1038\/s41392-023-01521-5","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"11016_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot, T., Sirard, C., Vormoor, J., et al. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367, 645\u2013648. https:\/\/doi.org\/10.1038\/367645a0","journal-title":"Nature"},{"key":"11016_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.stem.2014.02.006","volume":"14","author":"A Kreso","year":"2014","unstructured":"Kreso, A., & Dick, J. E. (2014). Evolution of the cancer stem cell model. Cell Stem Cell, 14, 275\u2013291. https:\/\/doi.org\/10.1016\/j.stem.2014.02.006","journal-title":"Cell Stem Cell"},{"key":"11016_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk1731","volume":"16","author":"C Larrue","year":"2024","unstructured":"Larrue, C., Mouche, S., Angelino, P., et al. (2024). Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models. Science Translational Medicine, 16, Article eadk1731. https:\/\/doi.org\/10.1126\/scitranslmed.adk1731","journal-title":"Science Translational Medicine"},{"key":"11016_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R., & Conrad, M. (2021). Ferroptosis: Mechanisms, biology and role in disease. Nature Reviews Molecular Cell Biology, 22, 266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"11016_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1182\/blood.2024024072","volume":"144","author":"N Hassan","year":"2024","unstructured":"Hassan, N., Yi, H., Malik, B., et al. (2024). Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4\/HOXA9-dependent AML. Blood, 144, 84\u201398. https:\/\/doi.org\/10.1182\/blood.2024024072","journal-title":"Blood"},{"key":"11016_CR10","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","volume":"23","author":"T Xu","year":"2019","unstructured":"Xu, T., Ding, W., Ji, X., et al. (2019). Molecular mechanisms of ferroptosis and its role in cancer therapy. Journal of Cellular and Molecular Medicine, 23, 4900\u20134912. https:\/\/doi.org\/10.1111\/jcmm.14511","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"11016_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/CM9.0000000000002239","volume":"136","author":"L Gong","year":"2023","unstructured":"Gong, L., Huang, D., Shi, Y., et al. (2023). Regulated cell death in cancer: From pathogenesis to treatment. Chinese Medical Journal, 136, 653\u2013665. https:\/\/doi.org\/10.1097\/CM9.0000000000002239","journal-title":"Chinese Medical Journal"},{"key":"11016_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"H-F Yan","year":"2021","unstructured":"Yan, H.-F., Zou, T., Tuo, Q.-Z., et al. (2021). Ferroptosis: Mechanisms and links with diseases. Signal Transduction and Targeted Therapy, 6, Article 49. https:\/\/doi.org\/10.1038\/s41392-020-00428-9","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"11016_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., et al. (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 149, 1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"11016_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma, S., Lessnick, S. L., Hahn, W. C., & Stockwell, B. R. (2003). Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell, 3, 285\u2013296. https:\/\/doi.org\/10.1016\/s1535-6108(03)00050-3","journal-title":"Cancer Cell"},{"key":"11016_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021). Broadening horizons: The role of ferroptosis in cancer. Nature Reviews. Clinical Oncology, 18, 280\u2013296. https:\/\/doi.org\/10.1038\/s41571-020-00462-0","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"11016_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., et al. (2017). Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 171, 273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"key":"11016_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/CM9.0000000000002642","volume":"136","author":"T Lyu","year":"2023","unstructured":"Lyu, T., Li, X., & Song, Y. (2023). Ferroptosis in acute leukemia. Chinese Medical Journal, 136, 886\u2013898. https:\/\/doi.org\/10.1097\/CM9.0000000000002642","journal-title":"Chinese Medical Journal"},{"key":"11016_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J., Cao, F., Yin, H.-L., et al. (2020). Ferroptosis: Past, present and future. Cell Death and Disease, 11, Article 88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death and Disease"},{"key":"11016_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5045\/br.2015.50.1.33","volume":"50","author":"S-R Jeon","year":"2015","unstructured":"Jeon, S.-R., Lee, J.-W., Jang, P.-S., et al. (2015). Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines. Blood Research, 50, 33\u201339. https:\/\/doi.org\/10.5045\/br.2015.50.1.33","journal-title":"Blood Research"},{"key":"11016_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1182\/blood-2011-12-399667","volume":"120","author":"M Roth","year":"2012","unstructured":"Roth, M., Will, B., Simkin, G., et al. (2012). Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. Blood, 120, 386\u2013394. https:\/\/doi.org\/10.1182\/blood-2011-12-399667","journal-title":"Blood"},{"key":"11016_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1084\/jem.20091488","volume":"207","author":"C Callens","year":"2010","unstructured":"Callens, C., Coulon, S., Naudin, J., et al. (2010). Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia. Journal of Experimental Medicine, 207, 731\u2013750. https:\/\/doi.org\/10.1084\/jem.20091488","journal-title":"Journal of Experimental Medicine"},{"key":"11016_CR22","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1182\/blood-2024-208616","volume":"144","author":"L Zhang","year":"2024","unstructured":"Zhang, L., Zhao, R., Akiyama, H., et al. (2024). Targeting lipid droplet biogenesis to enhance ferroptosis in acute myeloid leukemia. Blood, 144, 1400. https:\/\/doi.org\/10.1182\/blood-2024-208616","journal-title":"Blood"},{"key":"11016_CR23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3, 730\u2013737. https:\/\/doi.org\/10.1038\/nm0797-730","journal-title":"Nature Medicine"},{"key":"11016_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0002-9343(77)90124-3","volume":"63","author":"PJ Fialkow","year":"1977","unstructured":"Fialkow, P. J., Jacobson, R. J., & Papayannopoulou, T. (1977). Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte\/macrophage. American Journal of Medicine, 63, 125\u2013130. https:\/\/doi.org\/10.1016\/0002-9343(77)90124-3","journal-title":"American Journal of Medicine"},{"key":"11016_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2012.02.018","volume":"21","author":"B Zhang","year":"2012","unstructured":"Zhang, B., Ho, Y. W., Huang, Q., et al. (2012). Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. Cancer Cell, 21, 577\u2013592. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.018","journal-title":"Cancer Cell"},{"key":"11016_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","volume":"20","author":"D Vetrie","year":"2020","unstructured":"Vetrie, D., Helgason, G. V., & Copland, M. (2020). The leukaemia stem cell: Similarities, differences and clinical prospects in CML and AML. Nature Reviews Cancer, 20, 158\u2013173. https:\/\/doi.org\/10.1038\/s41568-019-0230-9","journal-title":"Nature Reviews Cancer"},{"key":"11016_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra061808","volume":"355","author":"CT Jordan","year":"2006","unstructured":"Jordan, C. T., Guzman, M. L., & Noble, M. (2006). Cancer stem cells. New England Journal of Medicine, 355, 1253\u20131261. https:\/\/doi.org\/10.1056\/NEJMra061808","journal-title":"New England Journal of Medicine"},{"key":"11016_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1182\/blood-2007-10-118331","volume":"112","author":"DC Taussig","year":"2008","unstructured":"Taussig, D. C., Miraki-Moud, F., Anjos-Afonso, F., et al. (2008). Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood, 112, 568\u2013575. https:\/\/doi.org\/10.1182\/blood-2007-10-118331","journal-title":"Blood"},{"key":"11016_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","volume":"138","author":"R Majeti","year":"2009","unstructured":"Majeti, R., Chao, M. P., Alizadeh, A. A., et al. (2009). CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell, 138, 286\u2013299. https:\/\/doi.org\/10.1016\/j.cell.2009.05.045","journal-title":"Cell"},{"key":"11016_CR30","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","volume":"94","author":"T Holyoake","year":"1999","unstructured":"Holyoake, T., Jiang, X., Eaves, C., & Eaves, A. (1999). Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood, 94, 2056\u20132064.","journal-title":"Blood"},{"key":"11016_CR31","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1182\/blood-2004-03-0901","volume":"104","author":"CV Cox","year":"2004","unstructured":"Cox, C. V., Evely, R. S., Oakhill, A., et al. (2004). Characterization of acute lymphoblastic leukemia progenitor cells. Blood, 104, 2919\u20132925. https:\/\/doi.org\/10.1182\/blood-2004-03-0901","journal-title":"Blood"},{"key":"11016_CR32","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3324\/haematol.2009.011726","volume":"95","author":"K Wilson","year":"2010","unstructured":"Wilson, K., Case, M., Minto, L., et al. (2010). Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34\u2009+\u2009CD38lowCD19\u2009+\u2009in B-lineage childhood acute lymphoblastic leukemia. Haematologica, 95, 679\u2013683. https:\/\/doi.org\/10.3324\/haematol.2009.011726","journal-title":"Haematologica"},{"key":"11016_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05002-3","volume":"22","author":"Q Zhu","year":"2024","unstructured":"Zhu, Q., Yang, Y., Chen, K., et al. (2024). Diffuse large B-cell lymphoma: The significance of CD8\u2009+\u2009tumor-infiltrating lymphocytes exhaustion mediated by TIM3\/galectin-9 pathway. Journal Of Translational Medicine, 22, Article 174. https:\/\/doi.org\/10.1186\/s12967-024-05002-3","journal-title":"Journal Of Translational Medicine"},{"key":"11016_CR34","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.19746\/j.cnki.issn.1009-2137.2021.04.056","volume":"29","author":"D-Q Yang","year":"2021","unstructured":"Yang, D-Q., Zhang, Y-M., Wu, L-Y., et al. (2021). [Research progress in the role of Tim3\/galectin-9 in hematological Malignancy\u2013Review]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 29, 1360\u20131364. https:\/\/doi.org\/10.19746\/j.cnki.issn.1009-2137.2021.04.056","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"11016_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","volume":"7","author":"Y Kikushige","year":"2010","unstructured":"Kikushige, Y., Shima, T., Takayanagi, S., et al. (2010). TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell, 7, 708\u2013717. https:\/\/doi.org\/10.1016\/j.stem.2010.11.014","journal-title":"Cell Stem Cell"},{"key":"11016_CR36","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1073\/pnas.1100551108","volume":"108","author":"M Jan","year":"2011","unstructured":"Jan, M., Chao, M. P., Cha, A. C., et al. (2011). Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. Proceedings of the National Academy of Sciences of the United States of America, 108, 5009\u20135014. https:\/\/doi.org\/10.1073\/pnas.1100551108","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11016_CR37","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","volume":"14","author":"CT Jordan","year":"2000","unstructured":"Jordan, C. T., Upchurch, D., Szilvassy, S. J., et al. (2000). The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia, 14, 1777\u20131784. https:\/\/doi.org\/10.1038\/sj.leu.2401903","journal-title":"Leukemia"},{"key":"11016_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000480448","volume":"138","author":"A Al-Mawali","year":"2017","unstructured":"Al-Mawali, A., Pinto, A. D., & Al-Zadjali, S. (2017). CD34\u2009+\u2009CD38-CD123\u2009+\u2009cells are present in virtually all acute myeloid leukaemia blasts: A promising single unique phenotype for minimal residual disease detection. Acta Haematologica, 138, 175\u2013181. https:\/\/doi.org\/10.1159\/000480448","journal-title":"Acta Haematologica"},{"key":"11016_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0292-z","volume":"9","author":"A Al-Mawali","year":"2016","unstructured":"Al-Mawali, A., Gillis, D., & Lewis, I. (2016). Immunoprofiling of leukemic stem cells CD34+\/CD38-\/CD123\u2009+\u2009delineate FLT3\/ITD-positive clones. Journal of Hematology & Oncology, 9, Article 61. https:\/\/doi.org\/10.1186\/s13045-016-0292-z","journal-title":"Journal of Hematology & Oncology"},{"key":"11016_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.stem.2009.04.018","volume":"5","author":"L Jin","year":"2009","unstructured":"Jin, L., Lee, E. M., Ramshaw, H. S., et al. (2009). Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell, 5, 31\u201342. https:\/\/doi.org\/10.1016\/j.stem.2009.04.018","journal-title":"Cell Stem Cell"},{"key":"11016_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03847-7","volume":"74","author":"H Ma","year":"2024","unstructured":"Ma, H., Yan, Z., Gu, R., et al. (2024). Loop33 \u00d7 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia. Cancer Immunology, Immunotherapy, 74, Article 20. https:\/\/doi.org\/10.1007\/s00262-024-03847-7","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"11016_CR42","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/ni1080","volume":"5","author":"KJ Hope","year":"2004","unstructured":"Hope, K. J., Jin, L., & Dick, J. E. (2004). Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nature Immunology, 5, 738\u2013743. https:\/\/doi.org\/10.1038\/ni1080","journal-title":"Nature Immunology"},{"key":"11016_CR43","doi-asserted-by":"publisher","first-page":"7178","DOI":"10.1038\/sj.onc.1207935","volume":"23","author":"CT Jordan","year":"2004","unstructured":"Jordan, C. T., & Guzman, M. L. (2004). Mechanisms controlling pathogenesis and survival of leukemic stem cells. Oncogene, 23, 7178\u20137187. https:\/\/doi.org\/10.1038\/sj.onc.1207935","journal-title":"Oncogene"},{"key":"11016_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00909-y","volume":"13","author":"W-T Wang","year":"2020","unstructured":"Wang, W.-T., Chen, T.-Q., Zeng, Z.-C., et al. (2020). The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia. Journal of Hematology & Oncology, 13, Article 78. https:\/\/doi.org\/10.1186\/s13045-020-00909-y","journal-title":"Journal of Hematology & Oncology"},{"key":"11016_CR45","doi-asserted-by":"publisher","first-page":"10494","DOI":"10.1073\/pnas.0704001104","volume":"104","author":"J Yang","year":"2007","unstructured":"Yang, J., Chai, L., Liu, F., et al. (2007). Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proceedings of the National Academy of Sciences of the United States of America, 104, 10494\u201310499. https:\/\/doi.org\/10.1073\/pnas.0704001104","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11016_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054790","volume":"24","author":"IS Tiong","year":"2023","unstructured":"Tiong, I. S., & Loo, S. (2023). Targeting measurable residual disease (MRD) in acute myeloid leukemia (AML): Moving beyond prognostication. International Journal of Molecular Sciences, 24, Article 4790. https:\/\/doi.org\/10.3390\/ijms24054790","journal-title":"International Journal of Molecular Sciences"},{"key":"11016_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00655","volume":"9","author":"MT Voso","year":"2019","unstructured":"Voso, M. T., Ottone, T., Lavorgna, S., et al. (2019). MRD in AML: The role of new techniques. Frontiers in Oncology, 9, Article 655. https:\/\/doi.org\/10.3389\/fonc.2019.00655","journal-title":"Frontiers in Oncology"},{"key":"11016_CR48","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.1038\/sj.onc.1204639","volume":"20","author":"PM Ayton","year":"2001","unstructured":"Ayton, P. M., & Cleary, M. L. (2001). Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene, 20, 5695\u20135707. https:\/\/doi.org\/10.1038\/sj.onc.1204639","journal-title":"Oncogene"},{"key":"11016_CR49","doi-asserted-by":"publisher","first-page":"11008","DOI":"10.1073\/pnas.0704271104","volume":"104","author":"N Hosen","year":"2007","unstructured":"Hosen, N., Park, C. Y., Tatsumi, N., et al. (2007). CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America, 104, 11008\u201311013. https:\/\/doi.org\/10.1073\/pnas.0704271104","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"11016_CR50","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nm1483","volume":"12","author":"L Jin","year":"2006","unstructured":"Jin, L., Hope, K. J., Zhai, Q., et al. (2006). Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nature Medicine, 12, 1167\u20131174. https:\/\/doi.org\/10.1038\/nm1483","journal-title":"Nature Medicine"},{"key":"11016_CR51","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1182\/blood.2019001808","volume":"136","author":"RZ Yusuf","year":"2020","unstructured":"Yusuf, R. Z., Saez, B., Sharda, A., et al. (2020). Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers. Blood, 136, 1303\u20131316. https:\/\/doi.org\/10.1182\/blood.2019001808","journal-title":"Blood"},{"key":"11016_CR52","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1080\/10428194.2017.1422862","volume":"59","author":"R Blume","year":"2018","unstructured":"Blume, R., Rempel, E., Manta, L., et al. (2018). The molecular signature of AML with increased ALDH activity suggests a stem cell origin. Leukaemia & Lymphoma, 59, 2201\u20132210. https:\/\/doi.org\/10.1080\/10428194.2017.1422862","journal-title":"Leukaemia & Lymphoma"},{"key":"11016_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-3-031-62731-6_18","volume":"1459","author":"S Aryal","year":"2024","unstructured":"Aryal, S., & Lu, R. (2024). HOXA9 regulome and Pharmacological interventions in leukemia. Advances in Experimental Medicine and Biology, 1459, 405\u2013430. https:\/\/doi.org\/10.1007\/978-3-031-62731-6_18","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"11016_CR54","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1182\/blood-2003-10-3722","volume":"103","author":"CW So","year":"2004","unstructured":"So, C. W., Karsunky, H., Wong, P., et al. (2004). Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9. Blood, 103, 3192\u20133199. https:\/\/doi.org\/10.1182\/blood-2003-10-3722","journal-title":"Blood"},{"key":"11016_CR55","doi-asserted-by":"publisher","first-page":"57811","DOI":"10.18632\/oncotarget.11063","volume":"7","author":"NHE Darwish","year":"2016","unstructured":"Darwish, N. H. E., Sudha, T., Godugu, K., et al. (2016). Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: Potential impact of BMI-1, TIM-3 and CLL-1. Oncotarget, 7, 57811\u201357820. https:\/\/doi.org\/10.18632\/oncotarget.11063","journal-title":"Oncotarget"},{"key":"11016_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep19995","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., Zhou, S., Yan, H., et al. (2016). MiR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1. Scientific Reports, 6, Article 19995. https:\/\/doi.org\/10.1038\/srep19995","journal-title":"Scientific Reports"},{"key":"11016_CR57","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.4081\/ejh.2018.2943","volume":"62","author":"I Rabinovich","year":"2018","unstructured":"Rabinovich, I., Sebasti\u00e3o, A. P. M., Lima, R. S., et al. (2018). Cancer stem cell markers ALDH1 and CD44+\/CD24- phenotype and their prognosis impact in invasive ductal carcinoma. European Journal of Histochemistry : Ejh, 62, 2943. https:\/\/doi.org\/10.4081\/ejh.2018.2943","journal-title":"European Journal of Histochemistry : Ejh"},{"key":"11016_CR58","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ccr.2010.10.032","volume":"18","author":"J Yeung","year":"2010","unstructured":"Yeung, J., Esposito, M. T., Gandillet, A., et al. (2010). \u03b2-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells. Cancer Cell, 18, 606\u2013618. https:\/\/doi.org\/10.1016\/j.ccr.2010.10.032","journal-title":"Cancer Cell"},{"key":"11016_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-13-7342-8_1","volume":"1143","author":"LM Gurska","year":"2019","unstructured":"Gurska, L. M., Ames, K., & Gritsman, K. (2019). Signaling pathways in leukemic stem cells. Advances in Experimental Medicine and Biology, 1143, 1\u201339. https:\/\/doi.org\/10.1007\/978-981-13-7342-8_1","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"11016_CR60","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/1389450117666160712092944","volume":"18","author":"GA Horne","year":"2017","unstructured":"Horne, G. A., Jackson, L., Helgason, V., & Holyoake, T. L. (2017). Stem cell guardians - Old and new perspectives in LSC biology. Current Drug Targets, 18, 405\u2013413. https:\/\/doi.org\/10.2174\/1389450117666160712092944","journal-title":"Current Drug Targets"},{"key":"11016_CR61","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/2159-8290.CD-22-0939","volume":"13","author":"A Waclawiczek","year":"2023","unstructured":"Waclawiczek, A., Lepp\u00e4, A.-M., Renders, S., et al. (2023). Combinatorial BCL2 family expression in acute myeloid leukemia stem cells predicts clinical response to azacitidine\/venetoclax. Cancer Discovery, 13, 1408\u20131427. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0939","journal-title":"Cancer Discovery"},{"key":"11016_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02148-3","volume":"10","author":"IRSB Dias","year":"2024","unstructured":"Dias, I. R. S. B., Costa, R. G. A., Rodrigues, ACBdaC., et al. (2024). Bithionol eliminates acute myeloid leukaemia stem-like cells by suppressing NF-\u03baB signalling and inducing oxidative stress, leading to apoptosis and ferroptosis. Cell Death Discovery, 10, Article 390. https:\/\/doi.org\/10.1038\/s41420-024-02148-3","journal-title":"Cell Death Discovery"},{"key":"11016_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44771-9","volume":"15","author":"MT Scott","year":"2024","unstructured":"Scott, M. T., Liu, W., Mitchell, R., et al. (2024). Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease. Nature Communications, 15, Article 651. https:\/\/doi.org\/10.1038\/s41467-024-44771-9","journal-title":"Nature Communications"},{"key":"11016_CR64","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1080\/10428194.2017.1387906","volume":"59","author":"L Peng","year":"2018","unstructured":"Peng, L., Tang, Y., Zhang, Y., et al. (2018). Structural maintenance of chromosomes 4 is required for leukemia stem cell maintenance in MLL-AF9 induced acute myeloid leukemia. Leukaemia & Lymphoma, 59, 2423\u20132430. https:\/\/doi.org\/10.1080\/10428194.2017.1387906","journal-title":"Leukaemia & Lymphoma"},{"key":"11016_CR65","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1182\/blood-2007-03-083048","volume":"110","author":"A van Rhenen","year":"2007","unstructured":"van Rhenen, A., van Dongen, G. A. M. S., Kelder, A., et al. (2007). The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood, 110, 2659\u20132666. https:\/\/doi.org\/10.1182\/blood-2007-03-083048","journal-title":"Blood"},{"key":"11016_CR66","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/stem.2897","volume":"36","author":"H Li","year":"2018","unstructured":"Li, H., Zhao, N., Li, Y., et al. (2018). C-MPL is a candidate surface marker and confers self-renewal, quiescence, chemotherapy resistance, and leukemia initiation potential in leukemia stem cells. Stem Cells, 36, 1685\u20131696. https:\/\/doi.org\/10.1002\/stem.2897","journal-title":"Stem Cells"},{"key":"11016_CR67","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature01593","volume":"423","author":"T Reya","year":"2003","unstructured":"Reya, T., Duncan, A. W., Ailles, L., et al. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423, 409\u2013414. https:\/\/doi.org\/10.1038\/nature01593","journal-title":"Nature"},{"key":"11016_CR68","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1084\/jem.20031615","volume":"199","author":"M Cobas","year":"2004","unstructured":"Cobas, M., Wilson, A., Ernst, B., et al. (2004). \u03b2-catenin is dispensable for hematopoiesis and lymphopoiesis. Journal of Experimental Medicine, 199, 221\u2013229. https:\/\/doi.org\/10.1084\/jem.20031615","journal-title":"Journal of Experimental Medicine"},{"key":"11016_CR69","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1182\/blood-2007-07-102558","volume":"111","author":"G Jeannet","year":"2008","unstructured":"Jeannet, G., Scheller, M., Scarpellino, L., et al. (2008). Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood, 111, 142\u2013149. https:\/\/doi.org\/10.1182\/blood-2007-07-102558","journal-title":"Blood"},{"key":"11016_CR70","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1101\/gad.17421911","volume":"25","author":"JM Perry","year":"2011","unstructured":"Perry, J. M., He, X. C., Sugimura, R., et al. (2011). Cooperation between both wnt\/\u03b2-catenin and PTEN\/PI3K\/akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion. Genes & Development, 25, 1928\u20131942. https:\/\/doi.org\/10.1101\/gad.17421911","journal-title":"Genes & Development"},{"key":"11016_CR71","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41556-020-0507-y","volume":"22","author":"JM Perry","year":"2020","unstructured":"Perry, J. M., Tao, F., Roy, A., et al. (2020). Overcoming Wnt-\u03b2-catenin dependent anticancer therapy resistance in leukaemia stem cells. Nature Cell Biology, 22, 689\u2013700. https:\/\/doi.org\/10.1038\/s41556-020-0507-y","journal-title":"Nature Cell Biology"},{"key":"11016_CR72","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1186624","volume":"327","author":"Y Wang","year":"2010","unstructured":"Wang, Y., Krivtsov, A. V., Sinha, A. U., et al. (2010). The wnt\/\u03b2-catenin pathway is required for the development of leukemia stem cells in AML. Science, 327, 1650\u20131653. https:\/\/doi.org\/10.1126\/science.1186624","journal-title":"Science"},{"key":"11016_CR73","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Zheng, L., Shang, W., et al. (2022). Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer. Cell Death and Differentiation, 29, 2190\u20132202. https:\/\/doi.org\/10.1038\/s41418-022-01008-w","journal-title":"Cell Death and Differentiation"},{"key":"11016_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174484","volume":"13","author":"V Tambay","year":"2021","unstructured":"Tambay, V., Raymond, V.-A., & Bilodeau, M. (2021). MYC rules: Leading glutamine metabolism toward a distinct cancer cell phenotype. Cancers, 13, Article 4484. https:\/\/doi.org\/10.3390\/cancers13174484","journal-title":"Cancers"},{"key":"11016_CR75","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41418-024-01324-3","volume":"31","author":"J Chu","year":"2024","unstructured":"Chu, J., Jiang, J., Fan, X., et al. (2024). A novel MYC-ZNF706-SLC7A11 regulatory circuit contributes to cancer progression and redox balance in human hepatocellular carcinoma. Cell Death and Differentiation, 31, 1333\u20131348. https:\/\/doi.org\/10.1038\/s41418-024-01324-3","journal-title":"Cell Death and Differentiation"},{"key":"11016_CR76","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou, E. D., Sach, A., Callahan, K., et al. (2013). BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell, 12, 329\u2013341. https:\/\/doi.org\/10.1016\/j.stem.2012.12.013","journal-title":"Cell Stem Cell"},{"key":"11016_CR77","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1158\/2159-8290.CD-23-1145","volume":"14","author":"AI Sheth","year":"2024","unstructured":"Sheth, A. I., Althoff, M. J., Tolison, H., et al. (2024). Targeting acute myeloid leukemia stem cells through perturbation of mitochondrial calcium. Cancer Discovery, 14, 1922\u20131939. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1145","journal-title":"Cancer Discovery"},{"key":"11016_CR78","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach, P., & Trumpp, A. (2023). Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica, 108, 353\u2013366. https:\/\/doi.org\/10.3324\/haematol.2022.280800","journal-title":"Haematologica"},{"key":"11016_CR79","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/ars.2009.3050","volume":"13","author":"ICC Low","year":"2010","unstructured":"Low, I. C. C., Chen, Z. X., & Pervaiz, S. (2010). Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxidants & Redox Signaling, 13, 807\u2013819. https:\/\/doi.org\/10.1089\/ars.2009.3050","journal-title":"Antioxidants & Redox Signaling"},{"key":"11016_CR80","doi-asserted-by":"publisher","unstructured":"(2025). Overexpression bcl-2 alleviated ferroptosis induced by molybdenum and cadmium co-exposure through inhibiting mitochondrial ROS in Duck kidneys. International Journal of Biological Macromolecules 291:139118. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139118","DOI":"10.1016\/j.ijbiomac.2024.139118"},{"key":"11016_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01800-2","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu, X., Wang, Y., Tan, J., et al. (2024). Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell Death Discovery, 10, Article 35. https:\/\/doi.org\/10.1038\/s41420-024-01800-2","journal-title":"Cell Death Discovery"},{"key":"11016_CR82","doi-asserted-by":"publisher","unstructured":"Xu, Y., Medina, C. G., Surman, D. R., et al. (2025). Co-targeting BCL-xL with MCL-1 induces lethal mitochondrial dysfunction in diffuse mesothelioma. Molecular Cancer Therapeutics(10). https:\/\/doi.org\/10.1158\/1535-7163.MCT-24-0873","DOI":"10.1158\/1535-7163.MCT-24-0873"},{"key":"11016_CR83","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","volume":"24","author":"DA Pollyea","year":"2018","unstructured":"Pollyea, D. A., Stevens, B. M., Jones, C. L., et al. (2018). Venetoclax with Azacitidine disrupts energy metabolism and targets leukemia stem cells in acute myeloid leukemia patients. Nature Medicine, 24, 1859\u20131866. https:\/\/doi.org\/10.1038\/s41591-018-0233-1","journal-title":"Nature Medicine"},{"key":"11016_CR84","doi-asserted-by":"publisher","first-page":"e399","DOI":"10.3324\/haematol.2019.229997","volume":"105","author":"K Mattes","year":"2020","unstructured":"Mattes, K., Gerritsen, M., Folkerts, H., et al. (2020). CD34\u2009+\u2009acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness genes and can be targeted by the BCL2 inhibitor venetoclax. Haematologica, 105, e399\u2013e403. https:\/\/doi.org\/10.3324\/haematol.2019.229997","journal-title":"Haematologica"},{"key":"11016_CR85","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.4252\/wjsc.v12.i11.1307","volume":"12","author":"M Luo","year":"2020","unstructured":"Luo, M., Li, J.-F., Yang, Q., et al. (2020). Stem cell quiescence and its clinical relevance. World Journal of Stem Cells, 12, 1307\u20131326. https:\/\/doi.org\/10.4252\/wjsc.v12.i11.1307","journal-title":"World Journal of Stem Cells"},{"key":"11016_CR86","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature09999","volume":"473","author":"A Klinakis","year":"2011","unstructured":"Klinakis, A., Lobry, C., Abdel-Wahab, O., et al. (2011). A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature, 473, 230\u2013233. https:\/\/doi.org\/10.1038\/nature09999","journal-title":"Nature"},{"key":"11016_CR87","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3892\/ijo_32_6_1335","volume":"32","author":"P-M Chen","year":"2008","unstructured":"Chen, P-M., Yen, C-C., Wang, W-S., et al. (2008). Down-regulation of notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia. International Journal of Oncology, 32, 1335\u20131341. https:\/\/doi.org\/10.3892\/ijo_32_6_1335","journal-title":"International Journal of Oncology"},{"key":"11016_CR88","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1084\/jem.20121527","volume":"210","author":"S Kannan","year":"2013","unstructured":"Kannan, S., Sutphin, R. M., Hall, M. G., et al. (2013). Notch activation inhibits AML growth and survival: A potential therapeutic approach. Journal of Experimental Medicine, 210, 321\u2013337. https:\/\/doi.org\/10.1084\/jem.20121527","journal-title":"Journal of Experimental Medicine"},{"key":"11016_CR89","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","volume":"18","author":"ME Figueroa","year":"2010","unstructured":"Figueroa, M. E., Wahab, O. A., Lu, C., et al. (2010). Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell, 18, 553\u2013567. https:\/\/doi.org\/10.1016\/j.ccr.2010.11.015","journal-title":"Cancer Cell"},{"key":"11016_CR90","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau, F., Dupont, S., Della Valle, V., et al. (2009). Mutation in TET2 in myeloid cancers. New England Journal of Medicine, 360, 2289\u20132301. https:\/\/doi.org\/10.1056\/NEJMoa0810069","journal-title":"New England Journal of Medicine"},{"key":"11016_CR91","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","volume":"114","author":"O Abdel-Wahab","year":"2009","unstructured":"Abdel-Wahab, O., Mullally, A., Hedvat, C., et al. (2009). Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood, 114, 144\u2013147. https:\/\/doi.org\/10.1182\/blood-2009-03-210039","journal-title":"Blood"},{"key":"11016_CR92","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1182\/blood-2016-01-693879","volume":"128","author":"KH Metzeler","year":"2016","unstructured":"Metzeler, K. H., Herold, T., Rothenberg-Thurley, M., et al. (2016). Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood, 128, 686\u2013698. https:\/\/doi.org\/10.1182\/blood-2016-01-693879","journal-title":"Blood"},{"key":"11016_CR93","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/cas.14033","volume":"110","author":"Y Chu","year":"2019","unstructured":"Chu, Y., Chen, Y., Li, M., et al. (2019). Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia. Cancer Science, 110, 2200\u20132210. https:\/\/doi.org\/10.1111\/cas.14033","journal-title":"Cancer Science"},{"key":"11016_CR94","doi-asserted-by":"publisher","first-page":"e1800311","DOI":"10.1002\/pmic.201800311","volume":"19","author":"GC Forcina","year":"2019","unstructured":"Forcina, G. C., & Dixon, S. J. (2019). GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics, 19, e1800311. https:\/\/doi.org\/10.1002\/pmic.201800311","journal-title":"Proteomics"},{"key":"11016_CR95","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K., Hendricks, J. M., Li, Z., et al. (2019). The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature, 575, 688\u2013692. https:\/\/doi.org\/10.1038\/s41586-019-1705-2","journal-title":"Nature"},{"key":"11016_CR96","doi-asserted-by":"publisher","first-page":"457","DOI":"10.34133\/research.0457","volume":"7","author":"\u8463\u5065","year":"2024","unstructured":"\u8463\u5065, \u5f20\u4e3d\u519b, et al. (2024). DNA methylation-mediated GPX4 transcriptional repression and osteoblast ferroptosis promote titanium particle-induced osteolysis. Research, 7, 457. https:\/\/doi.org\/10.34133\/research.0457","journal-title":"Research"},{"key":"11016_CR97","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S., Proneth, B., Tyurina, Y. Y., et al. (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology, 13, 91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239","journal-title":"Nature Chemical Biology"},{"key":"11016_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303484","volume":"10","author":"S Feng","year":"2023","unstructured":"Feng, S., Rao, Z., Zhang, J., et al. (2023). Inhibition of CARM1-mediated methylation of ACSL4 promotes ferroptosis in colorectal cancer. Advanced Science, 10, Article 2303484. https:\/\/doi.org\/10.1002\/advs.202303484","journal-title":"Advanced Science"},{"key":"11016_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00489-4","volume":"13","author":"S Feng","year":"2024","unstructured":"Feng, S., Yuan, Y., Lin, Z., et al. (2024). Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia. Experimental Hematology & Oncology, 13, Article 19. https:\/\/doi.org\/10.1186\/s40164-024-00489-4","journal-title":"Experimental Hematology & Oncology"},{"key":"11016_CR100","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/sj.leu.2401562","volume":"13","author":"J van Oostveen","year":"1999","unstructured":"van Oostveen, J., Bijl, J., Raaphorst, F., et al. (1999). The role of homeobox genes in normal hematopoiesis and hematological malignancies. Leukemia, 13, 1675\u20131690. https:\/\/doi.org\/10.1038\/sj.leu.2401562","journal-title":"Leukemia"},{"key":"11016_CR101","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1038\/s41467-023-40283-0","volume":"14","author":"P Coulombe","year":"2023","unstructured":"Coulombe, P., Cole, G., Fentiman, A., et al. (2023). Meis1 establishes the pre-hemogenic endothelial state prior to Runx1 expression. Nature Communications, 14, 4537. https:\/\/doi.org\/10.1038\/s41467-023-40283-0","journal-title":"Nature Communications"},{"key":"11016_CR102","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/5584_2021_705","volume":"1387","author":"N Meri\u00e7","year":"2022","unstructured":"Meri\u00e7, N., & Kocaba\u015f, F. (2022). The historical relationship between Meis1 and leukemia. Advances in Experimental Medicine and Biology, 1387, 127\u2013144. https:\/\/doi.org\/10.1007\/5584_2021_705","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"11016_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107825","volume":"300","author":"L Kobrossy","year":"2024","unstructured":"Kobrossy, L., Xu, W., Zhang, C., et al. (2024). Unraveling MLL1-fusion leukemia: Epigenetic revelations from an iPS cell point mutation. Journal of Biological Chemistry, 300, Article 107825. https:\/\/doi.org\/10.1016\/j.jbc.2024.107825","journal-title":"Journal of Biological Chemistry"},{"key":"11016_CR104","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1182\/blood-2010-12-327668","volume":"117","author":"SY Jo","year":"2011","unstructured":"Jo, S. Y., Granowicz, E. M., Maillard, I., et al. (2011). Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. Blood, 117, 4759\u20134768. https:\/\/doi.org\/10.1182\/blood-2010-12-327668","journal-title":"Blood"},{"key":"11016_CR105","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41586-019-1835-6","volume":"577","author":"L MacPherson","year":"2020","unstructured":"MacPherson, L., Anokye, J., Yeung, M. M., et al. (2020). HBO1 is required for the maintenance of leukaemia stem cells. Nature, 577, 266\u2013270. https:\/\/doi.org\/10.1038\/s41586-019-1835-6","journal-title":"Nature"},{"key":"11016_CR106","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1172\/JCI82978","volume":"126","author":"N Zhu","year":"2016","unstructured":"Zhu, N., Chen, M., Eng, R., et al. (2016). MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C. The Journal Of Clinical Investigation, 126, 997\u20131011. https:\/\/doi.org\/10.1172\/JCI82978","journal-title":"The Journal Of Clinical Investigation"},{"key":"11016_CR107","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","volume":"286","author":"TR Golub","year":"1999","unstructured":"Golub, T. R., Slonim, D. K., Tamayo, P., et al. (1999). Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science, 286, 531\u2013537. https:\/\/doi.org\/10.1126\/science.286.5439.531","journal-title":"Science"},{"key":"11016_CR108","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/10428194.2023.2275532","volume":"65","author":"N Meri\u00e7","year":"2024","unstructured":"Meri\u00e7, N., Albayrak, E., G\u00fclba\u015f, Z., & Kocaba\u015f, F. (2024). MEIS inhibitors reduce the viability of primary leukemia cells and stem cells by inducing apoptosis. Leukaemia & Lymphoma, 65, 187\u2013198. https:\/\/doi.org\/10.1080\/10428194.2023.2275532","journal-title":"Leukaemia & Lymphoma"},{"key":"11016_CR109","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/MOH.0000000000000245","volume":"23","author":"CT Collins","year":"2016","unstructured":"Collins, C. T., & Hess, J. L. (2016). Deregulation of the HOXA9\/MEIS1 axis in acute leukemia. Current Opinion in Hematology, 23, 354\u2013361. https:\/\/doi.org\/10.1097\/MOH.0000000000000245","journal-title":"Current Opinion in Hematology"},{"key":"11016_CR110","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","volume":"129","author":"R Sood","year":"2017","unstructured":"Sood, R., Kamikubo, Y., & Liu, P. (2017). Role of RUNX1 in hematological malignancies. Blood, 129, 2070\u20132082. https:\/\/doi.org\/10.1182\/blood-2016-10-687830","journal-title":"Blood"},{"key":"11016_CR111","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s0092-8674(00)80986-1","volume":"84","author":"T Okuda","year":"1996","unstructured":"Okuda, T., van Deursen, J., Hiebert, S. W., et al. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84, 321\u2013330. https:\/\/doi.org\/10.1016\/s0092-8674(00)80986-1","journal-title":"Cell"},{"key":"11016_CR112","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","volume":"19","author":"H Ye","year":"2016","unstructured":"Ye, H., Adane, B., Khan, N., et al. (2016). Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche. Cell Stem Cell, 19, 23\u201337. https:\/\/doi.org\/10.1016\/j.stem.2016.06.001","journal-title":"Cell Stem Cell"},{"key":"11016_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-019-0317-8","volume":"9","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z., Deng, X., Liu, Y., et al. (2019). PKM2, function and expression and regulation. Cell Bioscience, 9, Article 52. https:\/\/doi.org\/10.1186\/s13578-019-0317-8","journal-title":"Cell Bioscience"},{"key":"11016_CR114","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ccell.2018.08.016","volume":"34","author":"H Ye","year":"2018","unstructured":"Ye, H., Adane, B., Khan, N., et al. (2018). Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells. Cancer Cell, 34, 659-673e6. https:\/\/doi.org\/10.1016\/j.ccell.2018.08.016","journal-title":"Cancer Cell"},{"key":"11016_CR115","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","volume":"20","author":"M Skrti\u0107","year":"2011","unstructured":"Skrti\u0107, M., Sriskanthadevan, S., Jhas, B., et al. (2011). Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell, 20, 674\u2013688. https:\/\/doi.org\/10.1016\/j.ccr.2011.10.015","journal-title":"Cancer Cell"},{"key":"11016_CR116","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1182\/blood-2007-05-087759","volume":"110","author":"Y-Y Jang","year":"2007","unstructured":"Jang, Y.-Y., & Sharkis, S. J. (2007). A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood, 110, 3056\u20133063. https:\/\/doi.org\/10.1182\/blood-2007-05-087759","journal-title":"Blood"},{"key":"11016_CR117","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2174\/1568009617666171002144228","volume":"18","author":"S Sajadimajd","year":"2018","unstructured":"Sajadimajd, S., & Khazaei, M. (2018). Oxidative stress and cancer: The role of Nrf2. Current Cancer Drug Targets, 18, 538\u2013557. https:\/\/doi.org\/10.2174\/1568009617666171002144228","journal-title":"Current Cancer Drug Targets"},{"key":"11016_CR118","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2024.03.023","volume":"218","author":"J Lan","year":"2024","unstructured":"Lan, J., Liu, L., Zhao, W., et al. (2024). Unlocking the anticancer activity of gambogic acid: A shift towards ferroptosis via A GSH\/Trx dual antioxidant system. Free Radical Biology and Medicine, 218, 26\u201340. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.03.023","journal-title":"Free Radical Biology and Medicine"},{"key":"11016_CR119","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MOH.0000000000000152","volume":"22","author":"L Li","year":"2015","unstructured":"Li, L., & Bhatia, R. (2015). Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells. Current Opinion in Hematology, 22, 324\u2013329. https:\/\/doi.org\/10.1097\/MOH.0000000000000152","journal-title":"Current Opinion in Hematology"},{"key":"11016_CR120","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","volume":"129","author":"TL Holyoake","year":"2017","unstructured":"Holyoake, T. L., & Vetrie, D. (2017). The chronic myeloid leukemia stem cell: Stemming the tide of persistence. Blood, 129, 1595\u20131606. https:\/\/doi.org\/10.1182\/blood-2016-09-696013","journal-title":"Blood"},{"key":"11016_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.896426","volume":"12","author":"J Niu","year":"2022","unstructured":"Niu, J., Peng, D., & Liu, L. (2022). Drug resistance mechanisms of acute myeloid leukemia stem cells. Frontiers in Oncology, 12, Article 896426. https:\/\/doi.org\/10.3389\/fonc.2022.896426","journal-title":"Frontiers in Oncology"},{"key":"11016_CR122","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-05-0468","volume":"11","author":"A van Rhenen","year":"2005","unstructured":"van Rhenen, A., Feller, N., Kelder, A., et al. (2005). High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival. Clinical Cancer Research, 11, 6520\u20136527. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0468","journal-title":"Clinical Cancer Research"},{"key":"11016_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107587","volume":"9","author":"M Terwijn","year":"2014","unstructured":"Terwijn, M., Zeijlemaker, W., Kelder, A., et al. (2014). Leukemic stem cell frequency: A strong biomarker for clinical outcome in acute myeloid leukemia. PLoS One, 9, Article e107587. https:\/\/doi.org\/10.1371\/journal.pone.0107587","journal-title":"PLoS One"},{"key":"11016_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810157","volume":"22","author":"P Klener","year":"2021","unstructured":"Klener, P., Sovilj, D., Renesova, N., & Andera, L. (2021). BH3 mimetics in hematologic malignancies. International Journal of Molecular Sciences, 22, Article 10157. https:\/\/doi.org\/10.3390\/ijms221810157","journal-title":"International Journal of Molecular Sciences"},{"key":"11016_CR125","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1182\/blood.V91.3.991","volume":"91","author":"SH Kaufmann","year":"1998","unstructured":"Kaufmann, S. H., Karp, J. E., Svingen, P. A., et al. (1998). Elevated expression of the apoptotic regulator mcl-1 at the time of leukemic relapse. Blood, 91, 991\u20131000.","journal-title":"Blood"},{"key":"11016_CR126","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2159-8290.CD-19-0125","volume":"9","author":"T Nechiporuk","year":"2019","unstructured":"Nechiporuk, T., Kurtz, S. E., Nikolova, O., et al. (2019). The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells. Cancer Discovery, 9, 910\u2013925. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0125","journal-title":"Cancer Discovery"},{"key":"11016_CR127","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1089\/ars.2017.7176","volume":"29","author":"MJ Kerins","year":"2018","unstructured":"Kerins, M. J., & Ooi, A. (2018). The roles of NRF2 in modulating cellular iron homeostasis. Antioxidants & Redox Signaling, 29, 1756\u20131773. https:\/\/doi.org\/10.1089\/ars.2017.7176","journal-title":"Antioxidants & Redox Signaling"},{"key":"11016_CR128","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","volume":"378","author":"M Jongen-Lavrencic","year":"2018","unstructured":"Jongen-Lavrencic, M., Grob, T., Hanekamp, D., et al. (2018). Molecular minimal residual disease in acute myeloid leukemia. New England Journal of Medicine, 378, 1189\u20131199. https:\/\/doi.org\/10.1056\/NEJMoa1716863","journal-title":"New England Journal of Medicine"},{"key":"11016_CR129","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.3892\/ol.2019.10767","volume":"18","author":"Z Yu","year":"2019","unstructured":"Yu, Z., Liu, L., Shu, Q., et al. (2019). Leukemia stem cells promote chemoresistance by inducing downregulation of lumican in mesenchymal stem cells. Oncol Lett, 18, 4317\u20134327. https:\/\/doi.org\/10.3892\/ol.2019.10767","journal-title":"Oncol Lett"},{"key":"11016_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.618710","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang, Z., Chen, J., Wang, M., et al. (2021). One stone, two birds: The roles of Tim-3 in acute myeloid leukemia. Frontiers in Immunology, 12, Article 618710. https:\/\/doi.org\/10.3389\/fimmu.2021.618710","journal-title":"Frontiers in Immunology"},{"key":"11016_CR131","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16431","author":"T Sakoda","year":"2024","unstructured":"Sakoda, T., Kikushige, Y., Irifune, H., et al. (2024). TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation. Cancer Science. https:\/\/doi.org\/10.1111\/cas.16431","journal-title":"Cancer Science"},{"key":"11016_CR132","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stem.2010.06.014","volume":"7","author":"M Mohrin","year":"2010","unstructured":"Mohrin, M., Bourke, E., Alexander, D., et al. (2010). Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell, 7, 174\u2013185. https:\/\/doi.org\/10.1016\/j.stem.2010.06.014","journal-title":"Cell Stem Cell"},{"key":"11016_CR133","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.1158\/1078-0432.CCR-24-0796","volume":"30","author":"H Zhou","year":"2024","unstructured":"Zhou, H., Qin, D., Xie, C., et al. (2024). Combinations of HDAC inhibitor and PPAR agonist induce ferroptosis of leukemic stem cell-like cells in acute myeloid leukemia. Clinical Cancer Research, 30, 5430\u20135444. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-0796","journal-title":"Clinical Cancer Research"},{"key":"11016_CR134","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-206473","volume":"144","author":"C Bruedigam","year":"2024","unstructured":"Bruedigam, C., Dulatre, E. A., Lee, C., et al. (2024). Overcoming Ven\/Aza resistance through Imetelstat-mediated lipophagy in acute myeloid leukemia. Blood, 144, Article 52. https:\/\/doi.org\/10.1182\/blood-2024-206473","journal-title":"Blood"},{"key":"11016_CR135","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1182\/blood-2024-209077","volume":"144","author":"E Leveille","year":"2024","unstructured":"Leveille, E., Bramson, E., Robinson, M. E., et al. (2024). Metabolic determinants of ferroptosis in B-cell lymphoma. Blood, 144, 976. https:\/\/doi.org\/10.1182\/blood-2024-209077","journal-title":"Blood"},{"key":"11016_CR136","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias, J. D., Wang, X., Gygi, S. P., et al. (2014). Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature, 509, 105\u2013109. https:\/\/doi.org\/10.1038\/nature13148","journal-title":"Nature"},{"key":"11016_CR137","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3324\/haematol.2019.224899","volume":"105","author":"S Wang","year":"2020","unstructured":"Wang, S., He, X., Wu, Q., et al. (2020). Transferrin receptor 1-mediated iron uptake plays an essential role in hematopoiesis. Haematologica, 105, 2071\u20132082. https:\/\/doi.org\/10.3324\/haematol.2019.224899","journal-title":"Haematologica"},{"key":"11016_CR138","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41375-024-02169-y","volume":"38","author":"W Yi","year":"2024","unstructured":"Yi, W., Zhang, J., Huang, Y., et al. (2024). Ferritin-mediated mitochondrial iron homeostasis is essential for the survival of hematopoietic stem cells and leukemic stem cells. Leukemia, 38, 1003\u20131018. https:\/\/doi.org\/10.1038\/s41375-024-02169-y","journal-title":"Leukemia"},{"key":"11016_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2019.02.011","volume":"80","author":"M Gasparetto","year":"2019","unstructured":"Gasparetto, M., Pei, S., Minhajuddin, M., et al. (2019). Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy. Leukemia Research, 80, 1\u201310. https:\/\/doi.org\/10.1016\/j.leukres.2019.02.011","journal-title":"Leukemia Research"},{"key":"11016_CR140","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","volume":"30","author":"H Feng","year":"2020","unstructured":"Feng, H., Schorpp, K., Jin, J., et al. (2020). Transferrin receptor is a specific ferroptosis marker. Cell Rep, 30, 3411\u20133423. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.049. .e7.","journal-title":"Cell Rep"},{"key":"11016_CR141","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1039\/c7mt00143f","volume":"9","author":"E Gammella","year":"2017","unstructured":"Gammella, E., Buratti, P., Cairo, G., & Recalcati, S. (2017). The transferrin receptor: The cellular iron gate. Metallomics, 9, 1367\u20131375. https:\/\/doi.org\/10.1039\/c7mt00143f","journal-title":"Metallomics"},{"key":"11016_CR142","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/ejh.13183","volume":"102","author":"S Bertoli","year":"2019","unstructured":"Bertoli, S., Paubelle, E., B\u00e9rard, E., et al. (2019). Ferritin heavy\/light chain (FTH1\/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia. European Journal of Haematology, 102, 131\u2013142. https:\/\/doi.org\/10.1111\/ejh.13183","journal-title":"European Journal of Haematology"},{"key":"11016_CR143","doi-asserted-by":"publisher","first-page":"1068094","DOI":"10.3389\/fonc.2022.1068094","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Liu, L., Wei, J., et al. (2022). High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia. Frontiers in Oncology, 12, 1068094. https:\/\/doi.org\/10.3389\/fonc.2022.1068094","journal-title":"Frontiers in Oncology"},{"key":"11016_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010449","volume":"24","author":"L Rochette","year":"2022","unstructured":"Rochette, L., Dogon, G., Rigal, E., et al. (2022). Lipid peroxidation and iron metabolism: Two corner stones in the homeostasis control of ferroptosis. International Journal of Molecular Sciences, 24, Article 449. https:\/\/doi.org\/10.3390\/ijms24010449","journal-title":"International Journal of Molecular Sciences"},{"key":"11016_CR145","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1080\/15548627.2025.2469129","volume":"21","author":"C Luo","year":"2025","unstructured":"Luo, C., Liang, H., Ji, M., et al. (2025). Autophagy induced by mechanical stress sensitizes cells to ferroptosis by NCOA4-FTH1 axis. Autophagy, 21, 1263\u20131282. https:\/\/doi.org\/10.1080\/15548627.2025.2469129","journal-title":"Autophagy"},{"key":"11016_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091739","volume":"12","author":"R Yan","year":"2023","unstructured":"Yan, R., Lin, B., Jin, W., et al. (2023). NRF2, A superstar of ferroptosis. Antioxidants, 12, Article 1739. https:\/\/doi.org\/10.3390\/antiox12091739","journal-title":"Antioxidants"},{"key":"11016_CR147","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1182\/blood.2021013452","volume":"139","author":"NK Das","year":"2022","unstructured":"Das, N. K., Jain, C., Sankar, A., et al. (2022). Modulation of the HIF2\u03b1-NCOA4 axis in enterocytes attenuates iron loading in a mouse model of hemochromatosis. Blood, 139, 2547\u20132552. https:\/\/doi.org\/10.1182\/blood.2021013452","journal-title":"Blood"},{"key":"11016_CR148","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2023.01.020","volume":"186","author":"J Zhao","year":"2023","unstructured":"Zhao, J., Jia, Y., Mahmut, D., et al. (2023). Human hematopoietic stem cell vulnerability to ferroptosis. Cell, 186, 732-747e16. https:\/\/doi.org\/10.1016\/j.cell.2023.01.020","journal-title":"Cell"},{"key":"11016_CR149","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-023-06983-9","volume":"626","author":"Y Li","year":"2024","unstructured":"Li, Y., Ran, Q., Duan, Q., et al. (2024). 7-dehydrocholesterol dictates ferroptosis sensitivity. Nature, 626, 411\u2013418. https:\/\/doi.org\/10.1038\/s41586-023-06983-9","journal-title":"Nature"},{"key":"11016_CR150","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1397-3","volume":"38","author":"F Wang","year":"2019","unstructured":"Wang, F., Lv, H., Zhao, B., et al. (2019). Iron and leukemia: New insights for future treatments. Journal of Experimental & Clinical Cancer Research, 38, Article 406. https:\/\/doi.org\/10.1186\/s13046-019-1397-3","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"11016_CR151","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ccell.2020.05.014","volume":"38","author":"B Salik","year":"2020","unstructured":"Salik, B., Yi, H., Hassan, N., et al. (2020). Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia. Cancer Cell, 38, 263-278e6. https:\/\/doi.org\/10.1016\/j.ccell.2020.05.014","journal-title":"Cancer Cell"},{"key":"11016_CR152","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula, P., Zhuang, L., & Gan, B. (2021). Cystine transporter SLC7A11\/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein & Cell, 12, 599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5","journal-title":"Protein & Cell"},{"key":"11016_CR153","doi-asserted-by":"publisher","unstructured":"Chen, X., Li, J., Kang, R. Ferroptosis: Machinery and regulation. Autophagy 17:2054\u20132081. https:\/\/doi.org\/10.1080\/15548627.2020.1810918","DOI":"10.1080\/15548627.2020.1810918"},{"key":"11016_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02162-0","volume":"23","author":"C Zeng","year":"2024","unstructured":"Zeng, C., Nie, D., Wang, X., et al. (2024). Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL\u2009+\u2009leukemia stem cells. Molecular Cancer, 23, Article 240. https:\/\/doi.org\/10.1186\/s12943-024-02162-0","journal-title":"Molecular Cancer"},{"key":"11016_CR155","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","volume":"79","author":"F He","year":"2023","unstructured":"He, F., Zhang, P., Liu, J., et al. (2023). ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. Journal of Hepatology, 79, 362\u2013377. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.016","journal-title":"Journal of Hepatology"},{"key":"11016_CR156","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang, L., Liu, Y., Du, T., et al. (2020). ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death and Differentiation, 27, 662\u2013675. https:\/\/doi.org\/10.1038\/s41418-019-0380-z","journal-title":"Cell Death and Differentiation"},{"key":"11016_CR157","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00204-024-03681-x","volume":"98","author":"H Tang","year":"2024","unstructured":"Tang, H., Kang, R., Liu, J., & Tang, D. (2024). ATF4 in cellular stress, ferroptosis, and cancer. Archives of Toxicology, 98, 1025\u20131041. https:\/\/doi.org\/10.1007\/s00204-024-03681-x","journal-title":"Archives of Toxicology"},{"key":"11016_CR158","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01245-0","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang, Z., Liu, M., & Yang, Q. (2024). Glutamine and leukemia research: Progress and clinical prospects. Discover Oncology, 15, Article 391. https:\/\/doi.org\/10.1007\/s12672-024-01245-0","journal-title":"Discover Oncology"},{"key":"11016_CR159","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/0006-291x(77)90623-4","volume":"74","author":"S Bannai","year":"1977","unstructured":"Bannai, S., Tsukeda, H., & Okumura, H. (1977). Effect of antioxidants on cultured human diploid fibroblasts exposed to cystine-free medium. Biochemical and Biophysical Research Communications, 74, 1582\u20131588. https:\/\/doi.org\/10.1016\/0006-291x(77)90623-4","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"11016_CR160","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","volume":"710","author":"F Ursini","year":"1982","unstructured":"Ursini, F., Maiorino, M., Valente, M., et al. (1982). Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochimica Et Biophysica Acta, 710, 197\u2013211. https:\/\/doi.org\/10.1016\/0005-2760(82)90150-3","journal-title":"Biochimica Et Biophysica Acta"},{"key":"11016_CR161","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0003-9861(91)90250-m","volume":"288","author":"PG Geiger","year":"1991","unstructured":"Geiger, P. G., Thomas, J. P., & Girotti, A. W. (1991). Lethal damage to murine L1210 cells by exogenous lipid hydroperoxides: Protective role of glutathione-dependent selenoperoxidases. Archives of Biochemistry and Biophysics, 288, 671\u2013680. https:\/\/doi.org\/10.1016\/0003-9861(91)90250-m","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"11016_CR162","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","volume":"8","author":"A Seiler","year":"2008","unstructured":"Seiler, A., Schneider, M., F\u00f6rster, H., et al. (2008). Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metabolism, 8, 237\u2013248. https:\/\/doi.org\/10.1016\/j.cmet.2008.07.005","journal-title":"Cell Metabolism"},{"key":"11016_CR163","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S., SriRamaratnam, R., Welsch, M. E., et al. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell, 156, 317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010","journal-title":"Cell"},{"key":"11016_CR164","doi-asserted-by":"publisher","first-page":"16712","DOI":"10.1021\/acs.jmedchem.4c01518","volume":"67","author":"J Dong","year":"2024","unstructured":"Dong, J., Ma, F., Cai, M., et al. (2024). Heat shock protein 90 interactome-mediated proteolysis targeting chimera (HIM-PROTAC) degrading glutathione peroxidase 4 to trigger ferroptosis. Journal of Medicinal Chemistry, 67, 16712\u201316736. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01518","journal-title":"Journal of Medicinal Chemistry"},{"key":"11016_CR165","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1021\/acsmedchemlett.3c00571","volume":"15","author":"M Hu","year":"2024","unstructured":"Hu, M., Li, X., Wang, L., et al. (2024). ZX703: A small-molecule degrader of GPX4 inducing ferroptosis in human cancer cells. ACS Medicinal Chemistry Letters, 15, 406\u2013412. https:\/\/doi.org\/10.1021\/acsmedchemlett.3c00571","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"11016_CR166","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li, J., Liu, J., Zhou, Z., et al. (2023). Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Science Translational Medicine, 15, Article eadg3049. https:\/\/doi.org\/10.1126\/scitranslmed.adg3049","journal-title":"Science Translational Medicine"},{"key":"11016_CR167","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan, Y., Teng, H., Hang, Q., et al. (2023). SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nature Communications, 14, 3673. https:\/\/doi.org\/10.1038\/s41467-023-39401-9","journal-title":"Nature Communications"},{"key":"11016_CR168","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3192607","volume":"2022","author":"X Liu","year":"2022","unstructured":"Liu, X., Chen, C., Han, D., et al. (2022). SLC7A11\/GPX4 inactivation-mediated ferroptosis contributes to the pathogenesis of triptolide-induced cardiotoxicity. Oxidative Medicine and Cellular Longevity, 2022, Article 3192607. https:\/\/doi.org\/10.1155\/2022\/3192607","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"11016_CR169","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122444","volume":"11","author":"J Lee","year":"2022","unstructured":"Lee, J., & Roh, J.-L. (2022). SLC7A11 as a gateway of metabolic perturbation and ferroptosis vulnerability in cancer. Antioxidants, 11, Article 2444. https:\/\/doi.org\/10.3390\/antiox11122444","journal-title":"Antioxidants"},{"key":"11016_CR170","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.devcel.2024.03.002","volume":"59","author":"Z-F Miao","year":"2024","unstructured":"Miao, Z.-F., Sun, J.-X., Huang, X.-Z., et al. (2024). Metaplastic regeneration in the mouse stomach requires a reactive oxygen species pathway. Developmental Cell, 59, 1175-1191e7. https:\/\/doi.org\/10.1016\/j.devcel.2024.03.002","journal-title":"Developmental Cell"},{"key":"11016_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112212","volume":"134","author":"Y Cui","year":"2024","unstructured":"Cui, Y., Li, Y., Ji, J., et al. (2024). Dynamic single-cell RNA-seq reveals mechanism of selinexor-resistance in chronic myeloid leukemia. International Immunopharmacology, 134, Article 112212. https:\/\/doi.org\/10.1016\/j.intimp.2024.112212","journal-title":"International Immunopharmacology"},{"key":"11016_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves, F., Lane, D., Nguyen, T. P. M., et al. (2025). In defence of ferroptosis. Signal Transduction and Targeted Therapy, 10, Article 2. https:\/\/doi.org\/10.1038\/s41392-024-02088-5","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"11016_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q., Meng, Y., Li, D., et al. (2024). Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies. Signal Transduction and Targeted Therapy, 9, Article 55. https:\/\/doi.org\/10.1038\/s41392-024-01769-5","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"11016_CR174","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2353\/ajpath.2010.090823","volume":"177","author":"T Shirase","year":"2010","unstructured":"Shirase, T., Mori, K., Okazaki, Y., et al. (2010). Suppression of SLC11A2 expression is essential to maintain duodenal integrity during dietary iron overload. American Journal of Pathology, 177, 677\u2013685. https:\/\/doi.org\/10.2353\/ajpath.2010.090823","journal-title":"American Journal of Pathology"},{"key":"11016_CR175","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1089\/ars.2009.2891","volume":"12","author":"M-H Yoo","year":"2010","unstructured":"Yoo, M-H., Gu, X., Xu, X-M., et al. (2010). Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in alzheimer\u2019s disease. Antioxidants & Redox Signaling, 12, 819\u2013827. https:\/\/doi.org\/10.1089\/ars.2009.2891","journal-title":"Antioxidants & Redox Signaling"},{"key":"11016_CR176","unstructured":"Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/31101624\/. Accessed 6 Jan 2025."},{"key":"11016_CR177","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s10571-023-01388-8","volume":"43","author":"X Gao","year":"2023","unstructured":"Gao, X., Hu, W., Qian, D., et al. (2023). The mechanisms of ferroptosis under hypoxia. Cellular and Molecular Neurobiology, 43, 3329\u20133341. https:\/\/doi.org\/10.1007\/s10571-023-01388-8","journal-title":"Cellular and Molecular Neurobiology"},{"key":"11016_CR178","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang, D., Feng, Y., Zandkarimi, F., et al. (2023). Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell, 186, 2748-2764e22. https:\/\/doi.org\/10.1016\/j.cell.2023.05.003","journal-title":"Cell"},{"key":"11016_CR179","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","volume":"29","author":"W Li","year":"2023","unstructured":"Li, W., Liang, L., Liu, S., et al. (2023). FSP1: A key regulator of ferroptosis. Trends in Molecular Medicine, 29, 753\u2013764. https:\/\/doi.org\/10.1016\/j.molmed.2023.05.013","journal-title":"Trends in Molecular Medicine"},{"key":"11016_CR180","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","volume":"27","author":"A Anandhan","year":"2020","unstructured":"Anandhan, A., Dodson, M., Schmidlin, C. J., et al. (2020). Breakdown of an ironclad defense system: The critical role of NRF2 in mediating ferroptosis. Cell Chemical Biology, 27, 436\u2013447. https:\/\/doi.org\/10.1016\/j.chembiol.2020.03.011","journal-title":"Cell Chemical Biology"},{"key":"11016_CR181","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1074\/jbc.RA119.009548","volume":"295","author":"H Nishizawa","year":"2020","unstructured":"Nishizawa, H., Matsumoto, M., Shindo, T., et al. (2020). Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1. Journal of Biological Chemistry, 295, 69\u201382. https:\/\/doi.org\/10.1074\/jbc.RA119.009548","journal-title":"Journal of Biological Chemistry"},{"key":"11016_CR182","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/febs.16382","volume":"290","author":"H Nishizawa","year":"2023","unstructured":"Nishizawa, H., Yamanaka, M., & Igarashi, K. (2023). Ferroptosis: Regulation by competition between NRF2 and BACH1 and propagation of the death signal. The FEBS Journal, 290, 1688\u20131704. https:\/\/doi.org\/10.1111\/febs.16382","journal-title":"The FEBS Journal"},{"key":"11016_CR183","doi-asserted-by":"publisher","first-page":"13486","DOI":"10.18632\/aging.205257","volume":"15","author":"Z Ma","year":"2023","unstructured":"Ma, Z., Ye, W., Huang, X., et al. (2023). The ferroptosis landscape in acute myeloid leukemia. Aging, 15, 13486\u201313503. https:\/\/doi.org\/10.18632\/aging.205257","journal-title":"Aging"},{"key":"11016_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-023-00411-4","volume":"12","author":"X Liu","year":"2023","unstructured":"Liu, X., Zhong, S., Qiu, K., et al. (2023). Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis. Experimental Hematology & Oncology, 12, Article 47. https:\/\/doi.org\/10.1186\/s40164-023-00411-4","journal-title":"Experimental Hematology & Oncology"},{"key":"11016_CR185","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/ars.2009.2597","volume":"12","author":"VN Bochkov","year":"2010","unstructured":"Bochkov, V. N., Oskolkova, O. V., Birukov, K. G., et al. (2010). Generation and biological activities of oxidized phospholipids. Antioxidants & Redox Signaling, 12, 1009\u20131059. https:\/\/doi.org\/10.1089\/ars.2009.2597","journal-title":"Antioxidants & Redox Signaling"},{"key":"11016_CR186","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/cr200084z","volume":"111","author":"H Yin","year":"2011","unstructured":"Yin, H., Xu, L., & Porter, N. A. (2011). Free radical lipid peroxidation: Mechanisms and analysis. Chemical Reviews, 111, 5944\u20135972. https:\/\/doi.org\/10.1021\/cr200084z","journal-title":"Chemical Reviews"},{"key":"11016_CR187","doi-asserted-by":"publisher","first-page":"eadk1200","DOI":"10.1126\/sciadv.adk1200","volume":"10","author":"H Qian","year":"2024","unstructured":"Qian, H., Yi, R., Yingli, L., et al. (2024). Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases. Science Advances, 10, eadk1200. https:\/\/doi.org\/10.1126\/sciadv.adk1200","journal-title":"Science Advances"},{"key":"11016_CR188","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41556-021-00818-3","volume":"24","author":"H-L Zhang","year":"2022","unstructured":"Zhang, H.-L., Hu, B.-X., Li, Z.-L., et al. (2022). PKC\u03b2II phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nature Cell Biology, 24, 88\u201398. https:\/\/doi.org\/10.1038\/s41556-021-00818-3","journal-title":"Nature Cell Biology"},{"key":"11016_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1275774","volume":"10","author":"H Zhang","year":"2023","unstructured":"Zhang, H., Sun, C., Sun, Q., et al. (2023). Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies. Frontiers in Molecular Biosciences, 10, Article 1275774. https:\/\/doi.org\/10.3389\/fmolb.2023.1275774","journal-title":"Frontiers in Molecular Biosciences"},{"key":"11016_CR190","unstructured":"Grignano, E. (2022). Effets de la dihydroart\u00e9misinine sur la r\u00e9gulation du m\u00e9tabolisme du fer et de la ferroptose dans les leuc\u00e9mies aigu\u00ebs my\u00e9lo\u00efdes. Doctoral dissertation, Universit\u00e9 Paris Cit&#233."},{"key":"11016_CR191","unstructured":"M\u00fcller, S. R. (2022). Validation and characterization of monoclonal antibodies to target cancer stem cells and to develop new anti-cancer therapies. Doctoral dissertation, Technische Universit\u00e4t Darmstadt."},{"key":"11016_CR192","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13030298","volume":"13","author":"C Punziano","year":"2024","unstructured":"Punziano, C., Trombetti, S., Cesaro, E., et al. (2024). Antioxidant systems as modulators of ferroptosis: Focus on transcription factors. Antioxidants, 13, Article 298. https:\/\/doi.org\/10.3390\/antiox13030298","journal-title":"Antioxidants"},{"key":"11016_CR193","doi-asserted-by":"publisher","first-page":"47","DOI":"10.20517\/cdr.2024.127","volume":"7","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Yu, G., & Chen, X. (2024). Mechanism of ferroptosis resistance in cancer cells. Cancer Drug Resist, 7, 47. https:\/\/doi.org\/10.20517\/cdr.2024.127","journal-title":"Cancer Drug Resist"},{"key":"11016_CR194","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1084\/jem.20061444","volume":"203","author":"MK Middleton","year":"2006","unstructured":"Middleton, M. K., Zukas, A. M., Rubinstein, T., et al. (2006). Identification of 12\/15-lipoxygenase as a suppressor of myeloproliferative disease. Journal of Experimental Medicine, 203, 2529\u20132540. https:\/\/doi.org\/10.1084\/jem.20061444","journal-title":"Journal of Experimental Medicine"},{"key":"11016_CR195","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/ng.389","volume":"41","author":"Y Chen","year":"2009","unstructured":"Chen, Y., Hu, Y., Zhang, H., et al. (2009). Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nature Genetics, 41, 783\u2013792. https:\/\/doi.org\/10.1038\/ng.389","journal-title":"Nature Genetics"},{"key":"11016_CR196","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1158\/0008-5472.CAN-13-3012","volume":"74","author":"J Roos","year":"2014","unstructured":"Roos, J., Oancea, C., Heinssmann, M., et al. (2014). 5-lipoxygenase is a candidate target for therapeutic management of stem cell-like cells in acute myeloid leukemia. Cancer Research, 74, 5244\u20135255. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3012","journal-title":"Cancer Research"},{"key":"11016_CR197","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft, V. A. N., Bezjian, C. T., Pfeiffer, S., et al. (2020). GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Central Science, 6, 41\u201353. https:\/\/doi.org\/10.1021\/acscentsci.9b01063","journal-title":"ACS Central Science"},{"key":"11016_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107214","volume":"300","author":"J Kanefsky","year":"2024","unstructured":"Kanefsky, J., Basse, M., Sokei, J., et al. (2024). Disruption of polyunsaturated fatty acid biosynthesis drives STING-dependent acute myeloid leukemia cell maturation and death. Journal of Biological Chemistry, 300, Article 107214. https:\/\/doi.org\/10.1016\/j.jbc.2024.107214","journal-title":"Journal of Biological Chemistry"},{"key":"11016_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102227","volume":"52","author":"X Jiang","year":"2025","unstructured":"Jiang, X., Huang, Y., Hong, X., et al. (2025). Exogenous dihomo-\u03b3-linolenic acid triggers ferroptosis via ACSL4-mediated lipid metabolic reprogramming in acute myeloid leukemia cells. Translational Oncology, 52, Article 102227. https:\/\/doi.org\/10.1016\/j.tranon.2024.102227","journal-title":"Translational Oncology"},{"key":"11016_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03222-5","volume":"43","author":"J Feng","year":"2024","unstructured":"Feng, J., Bin, J.-L., Liao, X.-W., et al. (2024). The prognostic role of ACSL4 in postoperative adjuvant TACE-treated HCC: Implications for therapeutic response and mechanistic insights. Journal of Experimental & Clinical Cancer Research, 43, Article 306. https:\/\/doi.org\/10.1186\/s13046-024-03222-5","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"11016_CR201","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/0008-5472.CAN-23-2491","volume":"84","author":"Y Qiu","year":"2024","unstructured":"Qiu, Y., Wang, X., Sun, Y., et al. (2024). ACSL4-mediated membrane phospholipid remodeling induces integrin \u03b21 activation to facilitate triple-negative breast cancer metastasis. Cancer Research, 84, 1856\u20131871. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2491","journal-title":"Cancer Research"},{"key":"11016_CR202","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41418-024-01263-z","volume":"31","author":"H Miao","year":"2024","unstructured":"Miao, H., Meng, H., Zhang, Y., et al. (2024). FSP1 inhibition enhances Olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism. Cell Death and Differentiation, 31, 497\u2013510. https:\/\/doi.org\/10.1038\/s41418-024-01263-z","journal-title":"Cell Death and Differentiation"},{"key":"11016_CR203","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13020191","volume":"13","author":"Z Fi\u0161ar","year":"2024","unstructured":"Fi\u0161ar, Z., & Hroudov\u00e1, J. (2024). CoQ10 and mitochondrial dysfunction in alzheimer\u2019s disease. Antioxidants, 13, Article 191. https:\/\/doi.org\/10.3390\/antiox13020191","journal-title":"Antioxidants"},{"key":"11016_CR204","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3181759","volume":"2018","author":"J Huo","year":"2018","unstructured":"Huo, J., Xu, Z., Hosoe, K., et al. (2018). Coenzyme Q10 prevents senescence and dysfunction caused by oxidative stress in vascular endothelial cells. Oxidative Medicine and Cellular Longevity, 2018, Article 3181759. https:\/\/doi.org\/10.1155\/2018\/3181759","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"11016_CR205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-023-05477-8","volume":"6","author":"Q Sun","year":"2023","unstructured":"Sun, Q., Liu, D., Cui, W., et al. (2023). Cholesterol mediated ferroptosis suppression reveals essential roles of coenzyme Q and squalene. Commun Biol, 6, 1\u201315. https:\/\/doi.org\/10.1038\/s42003-023-05477-8","journal-title":"Commun Biol"},{"key":"11016_CR206","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/cbf.3869","volume":"41","author":"X Shen","year":"2023","unstructured":"Shen, X., Dong, P., Kong, J., et al. (2023). Targeted single-cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis-resistant state in hematologic malignancies. Cell Biochemistry and Function, 41, 1343\u20131356. https:\/\/doi.org\/10.1002\/cbf.3869","journal-title":"Cell Biochemistry and Function"},{"key":"11016_CR207","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/10715762.2024.2330413","volume":"58","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Zeng, Y., Huang, M., et al. (2024). Andrographolide attenuates sepsis-induced acute kidney injury by inhibiting ferroptosis through the Nrf2\/FSP1 pathway. Free Radical Research, 58, 156\u2013169. https:\/\/doi.org\/10.1080\/10715762.2024.2330413","journal-title":"Free Radical Research"},{"key":"11016_CR208","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula, P., Lei, G., Zhang, Y., et al. (2022). A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nature Communications, 13, Article 2206. https:\/\/doi.org\/10.1038\/s41467-022-29905-1","journal-title":"Nature Communications"},{"key":"11016_CR209","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/294303","volume":"2015","author":"J Liu","year":"2015","unstructured":"Liu, J., & Wang, Z. (2015). Increased oxidative stress as a selective anticancer therapy. Oxidative Medicine and Cellular Longevity, 2015, Article 294303. https:\/\/doi.org\/10.1155\/2015\/294303","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"11016_CR210","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1158\/2159-8290.CD-22-1297","volume":"13","author":"S Pei","year":"2023","unstructured":"Pei, S., Shelton, I. T., Gillen, A. E., et al. (2023). A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy. Cancer Discovery, 13, 2032\u20132049. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-1297","journal-title":"Cancer Discovery"},{"key":"11016_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68755-3","volume":"14","author":"Y Qin","year":"2024","unstructured":"Qin, Y., Pu, X., Hu, D., & Yang, M. (2024). Machine learning-based biomarker screening for acute myeloid leukemia prognosis and therapy from diverse cell-death patterns. Scientific Reports, 14, Article 17874. https:\/\/doi.org\/10.1038\/s41598-024-68755-3","journal-title":"Scientific Reports"},{"key":"11016_CR212","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45737-7","volume":"15","author":"W Jin","year":"2024","unstructured":"Jin, W., Dai, Y., Chen, L., et al. (2024). Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia. Nature Communications, 15, Article 1423. https:\/\/doi.org\/10.1038\/s41467-024-45737-7","journal-title":"Nature Communications"},{"key":"11016_CR213","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru, Q., Li, Y., Chen, L., et al. (2024). Iron homeostasis and ferroptosis in human diseases: Mechanisms and therapeutic prospects. Signal Transduction and Targeted Therapy, 9, Article 271. https:\/\/doi.org\/10.1038\/s41392-024-01969-z","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"11016_CR214","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy, B., Conrad, M., & Muckenthaler, M. (2024). Mechanisms controlling cellular and systemic iron homeostasis. Nature Reviews Molecular Cell Biology, 25, 133\u2013155. https:\/\/doi.org\/10.1038\/s41580-023-00648-1","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"11016_CR215","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01494-6","volume":"16","author":"D Huang","year":"2023","unstructured":"Huang, D., Ma, N., Li, X., et al. (2023). Advances in single-cell RNA sequencing and its applications in cancer research. Journal of Hematology & Oncology, 16, Article 98. https:\/\/doi.org\/10.1186\/s13045-023-01494-6","journal-title":"Journal of Hematology & Oncology"},{"key":"11016_CR216","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55231-9","volume":"15","author":"D Forte","year":"2024","unstructured":"Forte, D., Pellegrino, R. M., Falvo, P., et al. (2024). Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia. Nature Communications, 15, Article 10878. https:\/\/doi.org\/10.1038\/s41467-024-55231-9","journal-title":"Nature Communications"},{"key":"11016_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1207642","volume":"11","author":"D Fu","year":"2023","unstructured":"Fu, D., Zhang, B., Wu, S., et al. (2023). Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment. Frontiers in Cell and Developmental Biology, 11, Article 1207642. https:\/\/doi.org\/10.3389\/fcell.2023.1207642","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"11016_CR218","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1182\/blood.2022018258","volume":"141","author":"KM Rattigan","year":"2023","unstructured":"Rattigan, K. M., Zarou, M. M., & Helgason, G. V. (2023). Metabolism in stem cell\u2013driven leukemia: Parallels between hematopoiesis and immunity. Blood, 141, 2553\u20132565. https:\/\/doi.org\/10.1182\/blood.2022018258","journal-title":"Blood"},{"key":"11016_CR219","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36969-0","volume":"14","author":"MM Naldini","year":"2023","unstructured":"Naldini, M. M., Casirati, G., Barcella, M., et al. (2023). Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia. Nature Communications, 14, Article 1285. https:\/\/doi.org\/10.1038\/s41467-023-36969-0","journal-title":"Nature Communications"},{"key":"11016_CR220","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen, P., Hovestadt, V., Wadsworth, M., et al. (2019). Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell, 176, 1265\u20131281e24. https:\/\/doi.org\/10.1016\/j.cell.2019.01.031","journal-title":"Cell"},{"key":"11016_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102935","volume":"59","author":"E Solary","year":"2020","unstructured":"Solary, E. (2020). Tracking chronic myelomonocytic leukaemia diversity at the single cell level. EBioMedicine, 59, Article 102935. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102935","journal-title":"EBioMedicine"},{"key":"11016_CR222","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1182\/bloodadvances.2020001742","volume":"4","author":"H Herrmann","year":"2020","unstructured":"Herrmann, H., Sadovnik, I., Eisenwort, G., et al. (2020). Delineation of target expression profiles in CD34+\/CD38- and CD34+\/CD38\u2009+\u2009stem and progenitor cells in AML and CML. Blood Advances, 4, 5118\u20135132. https:\/\/doi.org\/10.1182\/bloodadvances.2020001742","journal-title":"Blood Advances"},{"key":"11016_CR223","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-203992","volume":"144","author":"S Liu","year":"2024","unstructured":"Liu, S., Ni, W., Zhu, F., et al. (2024). Salinomycin nanoparticles induce ferroptosis and synergize with the BCL-2 inhibitor venetoclax to promote AML cell death. Blood, 144, Article 5820. https:\/\/doi.org\/10.1182\/blood-2024-203992","journal-title":"Blood"},{"key":"11016_CR224","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1008893","volume":"9","author":"OO Izuegbuna","year":"2022","unstructured":"Izuegbuna, O. O. (2022). Polyphenols: Chemoprevention and therapeutic potentials in hematological malignancies. Frontiers in Nutrition, 9, Article 1008893. https:\/\/doi.org\/10.3389\/fnut.2022.1008893","journal-title":"Frontiers in Nutrition"},{"key":"11016_CR225","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212219","volume":"25","author":"Y Kubota","year":"2024","unstructured":"Kubota, Y., & Kimura, S. (2024). Current understanding of the role of autophagy in the treatment of myeloid leukemia. International Journal of Molecular Sciences, 25, Article 12219. https:\/\/doi.org\/10.3390\/ijms252212219","journal-title":"International Journal of Molecular Sciences"},{"key":"11016_CR226","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00594-w","volume":"12","author":"B Orlikova-Boyer","year":"2024","unstructured":"Orlikova-Boyer, B., Lorant, A., Gajulapalli, S. R., et al. (2024). Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation. Biomarker Research, 12, Article 47. https:\/\/doi.org\/10.1186\/s40364-024-00594-w","journal-title":"Biomarker Research"},{"key":"11016_CR227","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou, Y., Wang, J., Wu, J., et al. (2019). Ferroptosis, a new form of cell death: Opportunities and challenges in cancer. Journal of Hematology & Oncology, 12, Article 34. https:\/\/doi.org\/10.1186\/s13045-019-0720-y","journal-title":"Journal of Hematology & Oncology"},{"key":"11016_CR228","doi-asserted-by":"publisher","unstructured":"(2025). Synergistic effects of BET inhibitors and ferroptosis inducers via targeted Inhibition of the BRD4\/c-myc\/NRF2 pathway in AML. European Journal of Pharmacology 998:177652. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177652","DOI":"10.1016\/j.ejphar.2025.177652"},{"key":"11016_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06075-6","volume":"14","author":"C Xie","year":"2023","unstructured":"Xie, C., Zhou, H., Qin, D., et al. (2023). Bcl-2 inhibition combined with PPAR\u03b1 activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia. Cell Death and Disease, 14, Article 573. https:\/\/doi.org\/10.1038\/s41419-023-06075-6","journal-title":"Cell Death and Disease"},{"key":"11016_CR230","doi-asserted-by":"publisher","first-page":"833","DOI":"10.16352\/j.issn.1001-6325.2023.05.0833","volume":"43","author":"X Caixia","year":"2023","unstructured":"Caixia, X., Bintao, H., & Jian, H. (2023). Research progress of the anti-apoptotic inhibitor venetoclax in the treatment of myeloid leukemia. Basic Medicine and Clinical, 43, 833\u2013836. https:\/\/doi.org\/10.16352\/j.issn.1001-6325.2023.05.0833","journal-title":"Basic Medicine and Clinical"},{"key":"11016_CR231","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02394-8","volume":"24","author":"W Ye","year":"2025","unstructured":"Ye, W., Zhao, Y., Zhou, Y., et al. (2025). NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis. Molecular Cancer, 24, Article 201. https:\/\/doi.org\/10.1186\/s12943-025-02394-8","journal-title":"Molecular Cancer"},{"key":"11016_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-025-00882-z","author":"W Li","year":"2025","unstructured":"Li, W., Ji, T., Ye, J., et al. (2025). Ferroptosis enhances the therapeutic potential of oncolytic adenoviruses KD01 against cancer. Cancer Gene Therapy. https:\/\/doi.org\/10.1038\/s41417-025-00882-z","journal-title":"Cancer Gene Therapy"},{"key":"11016_CR233","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03211-6","volume":"23","author":"X Cao","year":"2025","unstructured":"Cao, X., Chen, M., Fang, T., et al. (2025). RSL3-loaded nanoparticles amplify the therapeutic potential of cold atmospheric plasma. Journal Of Nanobiotechnology, 23, Article 136. https:\/\/doi.org\/10.1186\/s12951-025-03211-6","journal-title":"Journal Of Nanobiotechnology"},{"key":"11016_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91519-6","volume":"15","author":"C Sansone","year":"2025","unstructured":"Sansone, C., Pistelli, L., & Brunet, C. (2025). The marine xanthophyll diatoxanthin as ferroptosis inducer in MDAMB231 breast cancer cells. Scientific Reports, 15, Article 8146. https:\/\/doi.org\/10.1038\/s41598-025-91519-6","journal-title":"Scientific Reports"},{"key":"11016_CR235","doi-asserted-by":"publisher","unstructured":"Uzun, T. (2025). Drugs and methods that enhance the anti-cancer efficacy of Artesunate. Frontiers in Pharmacology, 16. https:\/\/doi.org\/10.3389\/fphar.2025.1566700","DOI":"10.3389\/fphar.2025.1566700"},{"key":"11016_CR236","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114400","volume":"152","author":"T Yang","year":"2025","unstructured":"Yang, T., Yang, X., Wang, G., et al. (2025). Unraveling the crucial role of SDF-1 in osteoarthritis progression: IL6\/HIF-1\u03b1 positive feedback and chondrocyte ferroptosis. International Immunopharmacology, 152, Article 114400. https:\/\/doi.org\/10.1016\/j.intimp.2025.114400","journal-title":"International Immunopharmacology"},{"issue":"6","key":"11016_CR237","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaf042","volume":"80","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Dai, Y., Jin, R., et al. (2025). Ferroptosis activation contributes to kidney aging in mice by promoting tubular cell senescence. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, , Article glaf042. https:\/\/doi.org\/10.1093\/gerona\/glaf042","journal-title":"The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences"},{"key":"11016_CR238","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41121-z","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang, L., Song, A., Yang, Q.-C., et al. (2023). Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy. Nature Communications, 14, Article 5355. https:\/\/doi.org\/10.1038\/s41467-023-41121-z","journal-title":"Nature Communications"},{"key":"11016_CR239","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02132-6","volume":"23","author":"J Shi","year":"2024","unstructured":"Shi, J., Zhang, Z., Yin, H., et al. (2024). RNA m6A modification in ferroptosis: Implications for advancing tumor immunotherapy. Molecular Cancer, 23, Article 213. https:\/\/doi.org\/10.1186\/s12943-024-02132-6","journal-title":"Molecular Cancer"},{"key":"11016_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081128","volume":"12","author":"H Akiyama","year":"2023","unstructured":"Akiyama, H., Carter, B. Z., Andreeff, M., & Ishizawa, J. (2023). Molecular mechanisms of ferroptosis and updates of ferroptosis studies in cancers and leukemia. Cells, 12, Article 1128. https:\/\/doi.org\/10.3390\/cells12081128","journal-title":"Cells"},{"key":"11016_CR241","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-01002-7","volume":"30","author":"J Wei","year":"2024","unstructured":"Wei, J., Chai, Q., Qin, Y., et al. (2024). Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting NRF2. Molecular Medicine, 30, Article 224. https:\/\/doi.org\/10.1186\/s10020-024-01002-7","journal-title":"Molecular Medicine"},{"key":"11016_CR242","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","volume":"43","author":"K Cui","year":"2024","unstructured":"Cui, K., Wang, K., & Huang, Z. (2024). Ferroptosis and the tumor microenvironment. Journal of Experimental & Clinical Cancer Research : Cr, 43, 315. https:\/\/doi.org\/10.1186\/s13046-024-03235-0","journal-title":"Journal of Experimental & Clinical Cancer Research : Cr"},{"key":"11016_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.156920","volume":"500","author":"M Xu","year":"2024","unstructured":"Xu, M., Lai, F., Liu, H., et al. (2024). A nanozyme-based drug delivery system to amplify ferroptosis via MET inhibition and photodynamic therapy. Chemical Engineering Journal, 500, Article 156920. https:\/\/doi.org\/10.1016\/j.cej.2024.156920","journal-title":"Chemical Engineering Journal"},{"key":"11016_CR244","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei, G., Zhuang, L., & Gan, B. (2022). Targeting ferroptosis as a vulnerability in cancer. Nature Reviews Cancer, 22, 381\u2013396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0","journal-title":"Nature Reviews Cancer"},{"key":"11016_CR245","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov, H., Orhan, A., Christensen, J. P., & G\u00f6genur, I. (2021). Cytotoxic CD8\u2009+\u2009T cells in cancer and cancer immunotherapy. British Journal of Cancer, 124, 359\u2013367. https:\/\/doi.org\/10.1038\/s41416-020-01048-4","journal-title":"British Journal of Cancer"},{"key":"11016_CR246","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-3-030-62026-4_4","volume":"1301","author":"N Santana-Codina","year":"2021","unstructured":"Santana-Codina, N., Gikandi, A., & Mancias, J. D. (2021). The role of NCOA4-mediated ferritinophagy in ferroptosis. Advances in Experimental Medicine and Biology, 1301, 41\u201357. https:\/\/doi.org\/10.1007\/978-3-030-62026-4_4","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"11016_CR247","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/ajh.26650","volume":"97","author":"B Peter","year":"2022","unstructured":"Peter, B., Eisenwort, G., Sadovnik, I., et al. (2022). BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in ph\u2009+\u2009chronic myeloid leukemia. American Journal of Hematology, 97, 1215\u20131225. https:\/\/doi.org\/10.1002\/ajh.26650","journal-title":"American Journal of Hematology"},{"issue":"7","key":"11016_CR248","doi-asserted-by":"publisher","DOI":"10.1177\/00037028241292087","volume":"79","author":"M Muhammad","year":"2024","unstructured":"Muhammad, M., Shao, C.-S., Nawaz, R., et al. (2024). Using label-free raman spectroscopy integrated with microfluidic chips to probe ferroptosis networks in cells. Applied Spectroscopy, , Article 37028241292087. https:\/\/doi.org\/10.1177\/00037028241292087","journal-title":"Applied Spectroscopy"},{"key":"11016_CR249","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00861-4","volume":"30","author":"X Tan","year":"2024","unstructured":"Tan, X., He, Y., Yu, P., et al. (2024). The dual role of FSP1 in programmed cell death: Resisting ferroptosis in the cell membrane and promoting necroptosis in the nucleus of THP-1 cells. Molecular Medicine, 30, Article 102. https:\/\/doi.org\/10.1186\/s10020-024-00861-4","journal-title":"Molecular Medicine"},{"key":"11016_CR250","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01889-6","volume":"22","author":"T Sauerer","year":"2023","unstructured":"Sauerer, T., Vel\u00e1zquez, G. F., & Schmid, C. (2023). Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: Immune escape mechanisms and current implications for therapy. Molecular Cancer, 22, Article 180. https:\/\/doi.org\/10.1186\/s12943-023-01889-6","journal-title":"Molecular Cancer"},{"key":"11016_CR251","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2021.04.011","volume":"510","author":"S Kandel","year":"2021","unstructured":"Kandel, S., Adhikary, P., Li, G., & Cheng, K. (2021). The TIM3\/Gal9 signaling pathway: An emerging target for cancer immunotherapy. Cancer Letters, 510, 67\u201378. https:\/\/doi.org\/10.1016\/j.canlet.2021.04.011","journal-title":"Cancer Letters"},{"key":"11016_CR252","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36608","volume":"10","author":"MH Ashoub","year":"2024","unstructured":"Ashoub, M. H., Amiri, M., Fatemi, A., & Farsinejad, A. (2024). Evaluation of ferroptosis-based anti-leukemic activities of ZnO nanoparticles synthesized by a green route against pre-B acute lymphoblastic leukemia cells (NALM-6 and REH). Heliyon, 10, Article e36608. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36608","journal-title":"Heliyon"},{"key":"11016_CR253","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41375-024-02189-8","volume":"38","author":"X Yang","year":"2024","unstructured":"Yang, X., Liu, J., Liu, W., et al. (2024). CircFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation. Leukemia, 38, 1057\u20131071. https:\/\/doi.org\/10.1038\/s41375-024-02189-8","journal-title":"Leukemia"},{"key":"11016_CR254","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.stem.2022.12.003","volume":"30","author":"Y Cheng","year":"2023","unstructured":"Cheng, Y., Gao, Z., Zhang, T., et al. (2023). Decoding m6A RNA methylome identifies PRMT6-regulated lipid transport promoting AML stem cell maintenance. Cell Stem Cell, 30, 69-85e7. https:\/\/doi.org\/10.1016\/j.stem.2022.12.003","journal-title":"Cell Stem Cell"},{"key":"11016_CR255","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","volume":"30","author":"L Han","year":"2023","unstructured":"Han, L., Dong, L., Leung, K., et al. (2023). METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. Cell Stem Cell, 30, 52-68e13. https:\/\/doi.org\/10.1016\/j.stem.2022.12.006","journal-title":"Cell Stem Cell"},{"key":"11016_CR256","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2020.04.009","volume":"27","author":"C Shen","year":"2020","unstructured":"Shen, C., Sheng, Y., Zhu, A., et al. (2020). M6A demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia. Cell Stem Cell, 27, 64\u201380e9. https:\/\/doi.org\/10.1016\/j.stem.2020.04.009","journal-title":"Cell Stem Cell"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-11016-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-11016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:17:42Z","timestamp":1768342662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-11016-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":256,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["11016"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-11016-1","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}